Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Potential OPDIVO® (nivolumab) user playing the guitar while his wife sings.
Potential OPDIVO® (nivolumab) user playing the guitar while his wife sings.

Your fight against bladder
or urinary tract cancer

may start or continue here

OPDIVO, alone or in combination with chemotherapy,
is an FDA-approved immunotherapy option to treat certain adults with bladder or urinary tract cancer (urothelial carcinoma)

Actor portrayals.

Bladder or urinary tract cancer after surgery

OPDIVO is a treatment option for certain adults who have cancer in the bladder or urinary tract removed by surgery to help prevent it from coming back (adjuvant)

Advanced cancer in the bladder or urinary tract

OPDIVO with chemotherapy medicines cisplatin and gemcitabine is a treatment option for certain adults with previously untreated bladder or urinary tract cancer that has spread or cannot be removed by surgery

Previously treated advanced bladder or urinary tract cancer

OPDIVO is a treatment option for certain adults who have had prior treatment for advanced cancer in the bladder or urinary tract

OPDIVO and OPDIVO-based combination treatments will not work for everyone. Individual results may vary.

Man exploring real patients stories of experiences with OPDIVO® (nivolumab) or other OPDIVO-based combinations.

Patient stories

Real patients share their experiences with OPDIVO and OPDIVO-based treatments

Frequently asked questions about treatment with OPDIVO® (nivolumab).

Have questions about treatment?

We have answers about infusions, monitoring, and more

Hands exploring cost information and financial help for OPDIVO® (nivolumab).

Cost information and financial help

Find information about cost and access to OPDIVO



1506-US-2400131   04/24